NDUDI ANIEMEKA: Open Payments
NPI 1255447421 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,111 in 47 payments from 11 companies in 2025. Trend: 2023 $2,213 · 2024 $2,328 · 2025 $1,111
Food & beverage: $1,091Education: $20
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $305 |
| AstraZeneca Pharmaceuticals LP | 9 | $219 |
| PFIZER INC. | 6 | $134 |
| Teva Pharmaceuticals USA, Inc. | 3 | $89 |
| Ardelyx, Inc. | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| ABBVIE INC. | 3 | $59 |
| Novo Nordisk Inc | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Amgen Inc. | 2 | $35 |
Products named: Kerendia, FARXIGA, PREVNAR 20, AUSTEDO XR, IBSRELA, CAPLYTA, LINZESS, JARDIANCE.
Industry payments across IL — which companies pay providers there.
